Clostridium difficile Ribotype 027, Toxinotype III, the Netherlands
Ed J. Kuijper* , Renate J. van den Berg*, Sylvia Debast†, Caroline E. Visser‡, Dick Veenendaal§, Annet Troelstra¶, Tjallie van der Kooi#, Susan van den Hof#, and Daan W. Notermans#
Author affiliations: *Leiden University Medical Center, Leiden, the Netherlands; †St Jansdal Hospital, Harderwijk, the Netherlands; ‡Academic Medical Center, Amsterdam, the Netherlands; §The Public Health Laboratory, Haarlem, the Netherlands; ¶Utrecht Medical Center, Utrecht, the Netherlands; #National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands
The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.